14-day Premium Trial Subscription Try For FreeTry Free
$53.09
+0.150 (+0.283%)
At Close: May 02, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $50.35 $57.15 Thursday, 2nd May 2024 INCY stock ended at $53.09. This is 0.283% more than the trading day before Wednesday, 1st May 2024. During the day the stock fluctuated 2.26% from a day low at $52.28 to a day high of $53.46.
90 days $50.35 $61.87
52 weeks $50.27 $67.72

Historical Incyte Corporation prices

Date Open High Low Close Volume
Nov 01, 2023 $54.00 $54.59 $52.89 $54.37 2 096 614
Oct 31, 2023 $51.96 $54.08 $50.27 $53.93 3 577 842
Oct 30, 2023 $52.60 $52.99 $51.38 $52.16 3 243 143
Oct 27, 2023 $54.24 $54.24 $52.36 $52.54 1 448 663
Oct 26, 2023 $54.14 $54.39 $53.60 $54.27 1 757 043
Oct 25, 2023 $54.48 $54.69 $53.47 $54.25 1 362 988
Oct 24, 2023 $55.38 $55.90 $54.61 $54.95 1 629 901
Oct 23, 2023 $55.16 $55.40 $54.53 $55.10 1 375 498
Oct 20, 2023 $55.64 $56.13 $54.98 $55.13 2 070 977
Oct 19, 2023 $56.37 $56.64 $55.49 $55.64 1 581 790
Oct 18, 2023 $57.06 $57.69 $56.67 $56.82 1 314 105
Oct 17, 2023 $57.51 $57.89 $56.90 $57.19 1 131 344
Oct 16, 2023 $57.97 $58.06 $57.30 $57.63 1 140 143
Oct 13, 2023 $56.42 $57.63 $56.42 $57.61 1 220 491
Oct 12, 2023 $56.93 $56.93 $56.08 $56.57 1 294 116
Oct 11, 2023 $57.50 $57.80 $56.74 $56.96 1 266 779
Oct 10, 2023 $56.95 $57.74 $56.78 $57.24 1 473 769
Oct 09, 2023 $56.89 $57.01 $55.65 $56.68 2 210 139
Oct 06, 2023 $58.72 $58.76 $57.31 $57.33 1 466 604
Oct 05, 2023 $58.13 $58.87 $58.05 $58.81 1 483 100
Oct 04, 2023 $58.81 $58.81 $57.57 $58.16 1 522 737
Oct 03, 2023 $57.75 $58.69 $57.62 $58.56 1 812 512
Oct 02, 2023 $57.61 $58.09 $56.82 $58.06 1 790 957
Sep 29, 2023 $58.86 $58.86 $57.66 $57.77 1 319 532
Sep 28, 2023 $59.13 $59.33 $58.45 $58.61 763 576
Click to get the best stock tips daily for free!

About Incyte Corporation

Incyte Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as oncogenic drivers in various liquid and solid tumor types; and ICLUSIG, a kinase inhibitor to treat chr... INCY Profile

Golden Star

Ticker Date Change Price
BSCQ Apr 30 0.393% $19.09
EQC Apr 30 1.76% $18.72
HRB Apr 30 1.69% $47.23
REG Apr 30 1.35% $59.22
INGR Apr 30 0.576% $114.59
BSJP Apr 29 0.175% $22.91
LYG Apr 29 0.781% $2.56
ORA Apr 29 3.46% $64.48
DHT Apr 24 4.34% $11.28
LPLA Apr 19 2.62% $262.59
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT